Katherine Voith

417 total citations
28 papers, 281 citations indexed

About

Katherine Voith is a scholar working on Organic Chemistry, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Katherine Voith has authored 28 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Molecular Biology. Recurrent topics in Katherine Voith's work include Neuroscience and Neuropharmacology Research (4 papers), Receptor Mechanisms and Signaling (3 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Katherine Voith is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Receptor Mechanisms and Signaling (3 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Katherine Voith collaborates with scholars based in Canada and United States. Katherine Voith's co-authors include Leslie G. Humber, Geoffrey Metcalf, Béla Kovács, T. BOGRI, E. Greselin, A. V. Marton, Jorge Jaramillo, Morris L. Givner, Jehan F. Bagli and W. Lippmann and has published in prestigious journals such as Endocrinology, Journal of Medicinal Chemistry and Molecular Pharmacology.

In The Last Decade

Katherine Voith

27 papers receiving 229 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine Voith Canada 10 141 127 83 33 28 28 281
Hermann J. Gerhards Germany 11 135 1.0× 126 1.0× 84 1.0× 21 0.6× 62 2.2× 18 340
Yuzo Matsuoka Japan 12 136 1.0× 134 1.1× 68 0.8× 15 0.5× 28 1.0× 34 370
Nilgün Kula United States 11 208 1.5× 188 1.5× 54 0.7× 14 0.4× 38 1.4× 20 379
F.I. Carroll United States 11 210 1.5× 183 1.4× 91 1.1× 30 0.9× 17 0.6× 17 358
Evan F. Williams United States 11 132 0.9× 129 1.0× 39 0.5× 25 0.8× 9 0.3× 23 342
Alan D. Neubert United States 6 136 1.0× 145 1.1× 120 1.4× 21 0.6× 24 0.9× 7 370
Eleanor Garvey 9 165 1.2× 201 1.6× 113 1.4× 37 1.1× 18 0.6× 11 323
Makoto Oka Japan 12 196 1.4× 152 1.2× 87 1.0× 9 0.3× 27 1.0× 24 388
Junki Katsube Japan 10 178 1.3× 125 1.0× 117 1.4× 13 0.4× 71 2.5× 50 413
Chris M. Kinter United States 10 133 0.9× 127 1.0× 221 2.7× 15 0.5× 27 1.0× 12 414

Countries citing papers authored by Katherine Voith

Since Specialization
Citations

This map shows the geographic impact of Katherine Voith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Voith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Voith more than expected).

Fields of papers citing papers by Katherine Voith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Voith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Voith. The network helps show where Katherine Voith may publish in the future.

Co-authorship network of co-authors of Katherine Voith

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Voith. A scholar is included among the top collaborators of Katherine Voith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Voith. Katherine Voith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bagli, Jehan F., et al.. (1986). Troponoids. 7. Chemistry and dopamine agaonist activity of ciladopa and related aralkyltroponylpiperazines. Journal of Medicinal Chemistry. 29(2). 186–193. 3 indexed citations
2.
Voith, Katherine. (1984). The behavioral pharmacology of Ay‐27,110, a novel nonergot dopaminergic agonist. Drug Development Research. 4(4). 391–404. 2 indexed citations
3.
Voith, Katherine. (1980). Supersensitivity to apomorphine in experimentally induced hypokinesia and drug-induced modifications of the apomorphine response. Psychopharmacology. 70(3). 247–254. 6 indexed citations
4.
Humber, Leslie G., et al.. (1979). Mapping the dopamine receptor. 1. Features derived from modifications in ring E of the neuroleptic butaclamol. Journal of Medicinal Chemistry. 22(7). 761–767. 28 indexed citations
5.
Humber, Leslie G., et al.. (1979). Mapping the dopamine receptor. 2. Features derived from modifications in the rings A/B region of the neuroleptic butaclamol. Journal of Medicinal Chemistry. 22(7). 768–773. 21 indexed citations
6.
Humber, Leslie G., Katherine Voith, Thomas A. Pugsley, et al.. (1979). (+)-Isobutaclamol: a crystallographic, pharmacological, and biochemical study. Journal of Medicinal Chemistry. 22(8). 899–901. 5 indexed citations
7.
Humber, Leslie G., et al.. (1979). ChemInform Abstract: MAPPING THE DOPAMINE RECEPTOR. 1. FEATURES DERIVED FROM MODIFICATIONS IN RING G E OF THE NEUROLEPTIC BUTACLAMOL. Chemischer Informationsdienst. 10(50). 3 indexed citations
8.
Voith, Katherine, et al.. (1978). Neuroleptics related to butaclamol. Synthesis and some psychopharmacological effects of a series of 3-aryl analogues. Journal of Medicinal Chemistry. 21(7). 694–698. 4 indexed citations
9.
Humber, Leslie G., et al.. (1978). Neuroleptics related to butaclamol. An investigation of the effects of chlorine substituents on the aromatic rings. Journal of Medicinal Chemistry. 21(12). 1225–1231. 5 indexed citations
10.
Voith, Katherine. (1977). Synthetic MIF analogues. Part II: Dopa potentiation and fluphenazine antagonism.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 27(12). 2290–3. 10 indexed citations
11.
Voith, Katherine. (1977). Comparison of behavioral supersensitivity to apomorphine after fluphenazine dihydrochloride and fluphenazine decanoate treatment in rats. Progress in Neuro-Psychopharmacology. 1(3-4). 289–295. 6 indexed citations
12.
Voith, Katherine, et al.. (1976). Behavioral studies on the enantiomers of butaclamol demonstrating absolute optical specificity for neuroleptic activity. Canadian Journal of Physiology and Pharmacology. 54(4). 551–560. 15 indexed citations
13.
14.
Humber, Leslie G., et al.. (1975). Neuroleptic Agents of the Benzocycloheptapyridoisoquinoline Series. Molecular Pharmacology. 11(6). 833–840. 1 indexed citations
15.
Voith, Katherine, et al.. (1971). The effect of various antidepressant drugs upon the tetrabenazine-suppressed conditioned avoidance response in rats. Psychopharmacology. 20(3). 253–265. 14 indexed citations
16.
Kovács, Béla & Katherine Voith. (1966). INHIBITION OF ULCER FORMATION BY URINE EXTRACTS WITH ANTIHISTAMINE ACTIVITY. British Journal of Pharmacology and Chemotherapy. 27(1). 205–212. 2 indexed citations
17.
Voith, Katherine, et al.. (1966). DIFFERENCES IN GASTRIC ACID OUTPUT IN RESPONSE TO HISTAMINE BETWEEN MALE AND FEMALE GUINEA PIGS. Canadian Journal of Physiology and Pharmacology. 44(4). 515–520.
18.
Marton, A. V., E. Greselin, Morris L. Givner, & Katherine Voith. (1964). Effect of a Novel Hypocholesterolemic Agent,Trans-1,4-bis- (2- chlorobenzylaminomethyl)Cyclohexane Dihydrochloride (AY- 9944) on Adrenal Morphology. Endocrinology. 75(4). 469–476. 9 indexed citations
19.
Chappel, C. I., Katherine Voith, & G Róna. (1962). FURTHER STUDIES ON THE ROLE OF THE ADRENAL GLAND IN ADRENAL-REGENERATION HYPERTENSION. Canadian Journal of Biochemistry and Physiology. 40(11). 1567–1574. 1 indexed citations
20.
Chappel, C. I., Katherine Voith, & G Róna. (1962). FURTHER STUDIES ON THE ROLE OF THE ADRENAL GLAND IN ADRENAL-REGENERATION HYPERTENSION. Canadian Journal of Biochemistry and Physiology. 40(1). 1567–1574. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hermann J. Gerhards Breakdown of academic impact, for papers by Yuzo Matsuoka Breakdown of academic impact, for papers by Nilgün Kula Breakdown of academic impact, for papers by F.I. Carroll Breakdown of academic impact, for papers by Evan F. Williams Breakdown of academic impact, for papers by Alan D. Neubert Breakdown of academic impact, for papers by Eleanor Garvey Breakdown of academic impact, for papers by Makoto Oka Breakdown of academic impact, for papers by Junki Katsube Breakdown of academic impact, for papers by Chris M. Kinter
Rankless by CCL
2026